N-(3-methylbenzyl)-indole-3-carboxaldehyde | 428470-09-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: N-(3-methylbenzyl)-indole-3-carboxaldehyde
• 英文别名: 1-(3-methylbenzyl)-1H-indole-3-carbaldehyde；1-[(3-methylphenyl)methyl]indole-3-carbaldehyde
• CAS: 428470-09-1
• 化学式: C₁₇H₁₅NO
• mdl: MFCD02617077
• 分子量: 249.312
• InChiKey: GRXZPUPSNRQSLN-UHFFFAOYSA-N

物化性质

• 沸点：
  450.3±33.0 °C(Predicted)
• 密度：
  1.09±0.1 g/cm3(Predicted)
• 溶解度：
  14.5 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.117
• 拓扑面积：
  22
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-(3-methylbenzyl)-indole-3-carboxaldehyde 在 sodium tetrahydroborate 作用下， 以 乙醇 为溶剂， 生成 1-[(3-methylphenyl)methyl]-1H-indole-3-methanol
  参考文献：
  名称：

  Analogues and Derivatives of Oncrasin-1, a Novel Inhibitor of the C-Terminal Domain of RNA Polymerase II and Their Antitumor Activities

  摘要：

  To optimize the antitumor activity of oncrasin-1, a small molecule RNA polymerase II inhibitor, We evaluated 69 oncrasin-1 analogues for their cytotoxic activity against normal human epithelial cells and K-Ras mutant tumor cells. About 40 of those compounds were as potent as or more potent than oncrasin-1 in tumor cells and had a minimal cytotoxic effect on normal cells. Structure activity relationship analysis revealed that most of the active compounds contained either a hydroxymethyl group or an aldehyde group as a substitute at the 3-position of the indole. Both electron-donating and electron-withdrawing groups in the benzene ring were well tolerated. The hydroxymethyl compounds ranged from equipotent with to 100 times as potent as the corresponding aldehyde compounds. We tested three active analogues' effect on RNA, polymerase phosphorylation and found that they all inhibited phosphorylation of the C-terminal domain of RNA polymerase suggesting that the active compounds might act through the same mechanisms as oncrasin-1.

  DOI：

  10.1021/jm101417n
• 作为产物：
  描述：

  3-吲哚甲醛 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 生成 N-(3-methylbenzyl)-indole-3-carboxaldehyde
  参考文献：
  名称：

  芳硫半脲用作抗霉菌剂

  摘要：

  在筛选过程的基础上，我们将取代的硫半脲靶向为潜在的抗菌药。我们的目标是确定有助于抗寄生虫活性的关键结构要素，这些要素可用于开发有效的药物。合成了一系列的32种化合物，并评估了其对利什曼原虫的临床相关细胞内酰胺的功效。从这些化合物中，有22种化合物的EC 50值低于10μM，活性最高的衍生物（化合物14）的EC 50值为50在两个不同的哺乳动物细胞系中，其毒性仅为0.8μM，毒性极低。更高活性所需的最相关的结构元素表明，存在稠合的双环芳环如带有烷基或烷氧基取代基的萘是先决条件。由于易于合成，高活性和低毒性，最具活性的化合物可被视为进一步开发的先导。

  DOI：

  10.1016/j.ejmech.2016.07.014

文献信息

• Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents
  作者：Zheng Li、Mengyang Luo、Bin Cai、Lichuan Wu、Mengtian Huang、Haroon-Ur-Rashid、Jun Jiang、Lisheng Wang

  DOI：10.1016/j.bmcl.2018.01.017

  日期：2018.2

  Using matrine (1) as the lead compound, a series of new 14-(N-substituted-2-pyrrolemethylene) matrine and 14-(N-substituted-indolemethylene) matrine derivatives was designed and synthesized for their potential application as anticancer agents. The structure of these compounds was characterized by 1H NMR, 13C NMR and ESI-MS spectral analyses. The target compounds were evaluated for their in vitro cytotoxicity

  以苦参碱（1）为先导化合物，设计合成了一系列新的14-（N-取代-2-吡咯亚甲基）苦参碱和14-（N-取代-吲哚亚甲基）苦参碱衍生物，作为其潜在的抗癌剂。这些化合物的结构通过1 H NMR，13 C NMR和ESI-MS光谱分析进行表征。评价目标化合物对三种人类癌细胞系（SMMC-7721，A549和CNE2）的体外细胞毒性。结果显示，化合物A6和B21对具有IC 50的三种癌细胞系表现出最显着的抗癌活性值在3.42-8.05μM范围内，显示出比母体化合物（苦参碱）和阳性对照顺铂更好的活性。此外，膜联蛋白V-FITC / PI双重染色试验表明，化合物A6和B21可以剂量依赖性显着诱导SMMC-7721和CNE2细胞的凋亡。细胞周期分析还表明，化合物A6可导致SMMC-7721和CNE2细胞在G2 / M期的细胞周期停滞。
• Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones
  作者：Vida Mashayekhi、Kamaleddin Haj Mohammad Ebrahim Tehrani、Parisa Azerang、Soroush Sardari、Farzad Kobarfard

  DOI：10.1007/s12272-013-0242-z

  日期：2021.8

  Based on the structural elements of bioactive indole-based compounds, a series of novel 1-substituted indole-3-carboxaldehyde thiosemicarbazones were synthesized as potential antimycobacterial and anticancer agents. The derivatives were prepared via a two-step methodology including N-alkylation(benzylation) of indole-3-carboxaldehyde and conversion of the intermediate aldehydes to corresponding thiosemicarbazones. The derivatives were evaluated for their antimycobacterial activity and compounds 3d (R = propyl) and 3q (R = 4-nitrobenzyl) were among the most potent and selective derivatives with IC50 values of 0.9 and 1.9 μg/mL respectively. The anticancer activity of the derivatives was also assessed against a panel of tumor cell lines. Compounds 3t, 3u, 3v and 3w efficiently inhibited the majority of the cancer cell lines with considerable selectivity.

  基于生物活性吲哚类化合物的结构元素，合成了一系列新型1-取代吲哚-3-甲酰基缩氨基硫脲作为潜在的抗分枝杆菌和抗癌剂。这些衍生物通过两步法合成：包括吲哚-3-甲酰基的N-烷基化（苄基化）以及中间体醛转化为相应的缩氨基硫脲。评估了这些衍生物的抗分枝杆菌活性，其中化合物3d（R = 丙基）和3q（R = 4-硝基苄基）是活性最强且选择性最高的衍生物，其IC50值分别为0.9和1.9 μg/mL。还评估了这些衍生物对一组肿瘤细胞系的抗癌活性。化合物3t、3u、3v和3w能有效抑制大多数癌细胞系，并具有相当的选择性。
• Synthesis and Antimycobacterial Activity of Novel Thiadiazolylhydrazones of 1-Substituted Indole-3-carboxaldehydes
  作者：Kamaleddin Haj Mohammad Ebrahim Tehrani、Vida Mashayekhi、Parisa Azerang、Soroush Sardari、Farzad Kobarfard、Kobra Rostamizadeh

  DOI：10.1111/cbdd.12230

  日期：2014.2

  derivatives were tested for their antimycobacterial activity against Mycobacterium bovis BCG, and the results revealed that among the synthesized compounds, thiadiazole derivatives 4e, 4f, 4n, 4p, 4q, and 4t exhibited the highest activity with IC50 value of 3.91 μg/mL. The results indicate that the thiadiazole moiety plays a vital role in exerting antimycobacterial activity.

  制备了一系列新的取代吲哚的硫代碳氢azo及其相应的噻二唑衍生物，并通过不同的分析和光谱方法证实了它们的结构。通过顺序合成策略制备衍生物，包括在吲哚环的N -1位被各种脂族和苄基取代基取代，然后与硫代碳酰肼缩合，最后由原甲酸三乙酯环化。测试了这些衍生物对牛分枝杆菌BCG的抗分枝杆菌活性，结果表明，在合成的化合物中，噻二唑衍生物4e，4f，4n，4p，4q和4t表现出最高的活性，IC 50值为3.91μg/ mL。结果表明，噻二唑部分在发挥抗分枝杆菌活性中起着至关重要的作用。
• Novel<i>N</i>-Substituted ((1<i>H</i>-indol-3-yl)methylene)benzohydrazides and ((1<i>H</i>-indol-3-yl)methylene)-2-phenylhydrazines: Synthesis and Antiplatelet Aggregation Activity
  作者：Nadia Kalhor、Matin Mardani、Sepideh Abdollahzadeh、Mona Vakof、Marjan Esfahani Zadeh、Kamaleddin Haj Mohammad Ebrahim Tehrani、Farzad Kobarfard、Shohreh Mohebbi

  DOI：10.1002/bkcs.10531

  日期：2015.11

  antiplatelet hydrazone derivatives, some new indole‐based derivatives were designed and synthesized as potential antiplatelet agents. Synthesis of the derivatives was accomplished by substitution at the N – 1 position of indole‐3‐carboxaldehyde and reacting the resulting intermediates with either phenylhydrazine of benzoylhydrazide. The structure of the synthesized compounds was confirmed by different spectral

  根据我们先前对抗血小板衍生物的研究，设计并合成了一些新的基于吲哚的衍生物作为潜在的抗血小板药。衍生物的合成是通过在 吲哚-3-羧醛的N -1位进行取代并使所得的中间体与苯甲酰肼的苯肼反应而完成的。合成的化合物的结构通过质谱，1 H-NMR和IR光谱等不同的光谱方法得到证实。测试了这些衍生物抑制人血小板聚集的能力，其中花生四烯酸（AA），二磷酸腺苷ADP和胶原蛋白被用作聚集诱导剂。化合物（2a–2f）对AA诱导的血小板聚集表现出相当大的活​​性。其中，化合物2a，2b和2f是最有效的衍生物，其IC 50值可与阿司匹林作为标准药物相比。结构-活性关系的分析表明，随着吲哚N  -1上取代基的增加，抗血小板活性降低，因此表明该位置的位阻在被测化合物的活性中起主要作用。
• Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents
  作者：Zheng Li、Mengyang Luo、Bin Cai、Haroon-Ur-Rashid、Mengtian Huang、Jun Jiang、Lisheng Wang、Lichuan Wu

  DOI：10.1016/j.ejmech.2018.08.021

  日期：2018.9

  Taking sophoridine as a lead compound, 58 sophoridine derivatives were designed, synthesized and evaluated for their antiproliferative activity in the HepG2 cancer cell line. Among the 58 compounds, 33 compounds showed potent antiproliferative activity with IC50 less than 10 μM. Compound 5w showed the most potent anti-proliferative activity in the HepG2 cancer cell line. Thus, we further extended our

  以槐定碱为先导化合物，设计，合成并评价了58种槐定碱衍生物在HepG2癌细胞系中的抗增殖活性。在58种化合物中，有33种化合物显示出有效的抗增殖活性，IC 50小于10μM。化合物5w在HepG2癌细胞系中显示出最有效的抗增殖活性。因此，我们进一步扩展了在6种癌细胞系（HepG2，SMMC-7721，Hela，CNE1，CNE2和MCF7）中5w的抗增殖活性的表征。代表性化合物5w在所有测试的具有IC 50的细胞系中均显示出强大的抗增殖活性值在0.93-1.89μM之间，远低于槐定啶。在这里，我们报道了槐定碱系列化合物的构效关系（SAR），这表明在槐定啶的14个碳原子上引入N-苄基吲哚基团可以显着增强抗增殖活性。通过分子对接和酶促测定，发现化合物5w能够抑制DNA Topo I的活性。此外，凋亡测定表明，化合物5w通过激活caspase-3可以剂量依赖性显着诱导HepG2细胞凋亡。 ，增加